Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03321214 · ClinicalTrials.gov registry record · NA
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03321214 is a NA study that has completed, run by Columbia University. The registered enrollment target is 30 participants.
The verdict
NCT03321214, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The current treatment for celiac disease is a strict 100% gluten free diet. Little is known about the best way to promote adherence to such a strict diet and how to maximize quality of life at the same time. This pilot will look at the utility of a new innovation to promote gluten free diet adherence - a portable gluten sensor device. Participants will be 30 teenagers and adults with celiac disease recruited from the Celiac Disease Center at Columbia University in New York City. Before and after the intervention, participants will be asked about their adherence to a gluten free diet, quality of life, symptoms, and feelings of anxiety, and depression. This pilot data will help to inform interventions that the investigators hope to test in a larger NIH-funded trial to better understand the best ways to promote adherence and quality of life in celiac patients.
Interventions
- OTHER Gluten Sensor Dose-Finding Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03321214
The ClinicalTrials.gov registry entry for NCT03321214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gluten Sensor Dose-Finding Intervention is the first listed.
NCT03321214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03321214 about?
NCT03321214 is a clinical study titled "Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease". The current treatment for celiac disease is a strict 100% gluten free diet. Little is known about the best way to promote adherence to such a strict diet and how to maximize quality of life at the same time. This pilot will look at the utility of a new innovation to promote gluten free diet adheren...
What is the current status of trial NCT03321214?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-01-02. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03321214?
The interventions under investigation include: Gluten Sensor Dose-Finding Intervention (OTHER).
Who is sponsoring clinical trial NCT03321214?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.